SOLIFENACIN TABS 5 MG

This tender, originating from Jordan and sourced via joneps_jo, concerns the procurement of Solifenacin Tablets 5 mg. This is a pharmaceutical supply tender, likely managed by a national healthcare authority, hospital network, or a government procurement agency tasked with acquiring essential medications. Solifenacin is a medication used to treat symptoms of overactive bladder, such as urinary incontinence, urgency, and frequency. The tender seeks the supply of tablets in the 5 mg dosage strength. Bidders are expected to meet rigorous pharmaceutical quality standards, including compliance with Good Manufacturing Practices (GMP). Comprehensive product documentation is a standard requirement, which typically includes detailed specifications for the active pharmaceutical ingredient (API) and the finished tablet, manufacturing process information, and quality control test results. Certificates of analysis for supplied batches and evidence of product stability are usually mandatory. Packaging must be suitable for pharmaceutical products, ensuring integrity during transport and storage and complying with Jordanian labeling regulations. Suppliers must possess valid manufacturing licenses and relevant regulatory approvals. The evaluation will consider product quality, regulatory compliance, supply chain reliability, and cost-effectiveness.